Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020221966 - INHALABLE GASEOUS MIXTURE FOR TREATING CHRONIC PAIN IN PATIENTS RECEIVING DRUGS FROM MULTIPLE THERAPEUTIC CLASSES

Publication Number WO/2020/221966
Publication Date 05.11.2020
International Application No. PCT/FR2019/052400
International Filing Date 10.10.2019
IPC
A61K 33/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
CPC
A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
Applicants
  • L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE [FR]/[FR]
Inventors
  • LECOURT, Laurent
  • BESSIERE, Baptiste
  • HOUETO, Patrick
  • DELVAL, Cécile
  • RAMIREZ, Juan Fernando
Agents
  • PITTIS, Olivier
Priority Data
190462602.05.2019FR
Publication Language French (FR)
Filing Language French (FR)
Designated States
Title
(EN) INHALABLE GASEOUS MIXTURE FOR TREATING CHRONIC PAIN IN PATIENTS RECEIVING DRUGS FROM MULTIPLE THERAPEUTIC CLASSES
(FR) MÉLANGE GAZEUX INHALABLE POUR TRAITER LES DOULEURS CHRONIQUES CHEZ DES PATIENTS RECEVANT DES MÉDICAMENTS DE PLUSIEURS CLASSES THÉRAPEUTIQUES
Abstract
(EN)
The invention relates to a gaseous mixture containing 50% of nitrous oxide (N2O) and at least 20% of oxygen (O2) (mol %) for use as an inhalable medicament for treating chronic pain in a human patient treated with a plurality of drug substances of at least two different therapeutic classes.
(FR)
L'invention concerne un mélange gazeux contenant 50% de protoxyde d'azote (N2O) et au moins 20% d'oxygène (O2) (% molaires) pour une utilisation en tant que médicament inhalable pour traiter des douleurs chroniques chez un patient humain traité par plusieurs substances médicamenteuses d'au moins deux classes thérapeutiques différentes.
Latest bibliographic data on file with the International Bureau